The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute
- 1 April 1995
- Vol. 75 (S7) , 1869-1873
- https://doi.org/10.1002/1097-0142(19950401)75:7+<1869::aid-cncr2820751617>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993
- Advances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of TherapyNew England Journal of Medicine, 1993
- The Next Era for Prostate Cancer Controlled Clinical TrialsPublished by American Medical Association (AMA) ,1993
- The relationship of prostate‐specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection projectCancer, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Lack of benefit from semi‐annual screening for cancer of the lung: Follow‐up report of a randomized controlled trial on a population of high‐risk males in czechoslovakiaInternational Journal of Cancer, 1990
- Assessment of Screening for Prostate Cancer Using the Digital Rectal ExaminationJournal of Urology, 1989
- Cancer screening degrees of proof and practical applicationCancer, 1988
- Impact of Routine Screening for Adenocarcinoma of the Prostate on Stage DistributionJournal of Urology, 1987
- Staging Prostatic Cancer: A Different DistributionJournal of Urology, 1979